Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

20.11.2017

12 AIDS
6 AIDS Res Hum Retroviruses
1 Ann Intern Med
3 Antimicrob Agents Chemother
1 Br J Haematol
5 Clin Infect Dis
12 J Acquir Immune Defic Syndr
1 J Am Acad Dermatol
1 J Clin Oncol
3 J Infect Dis
3 J Virol
1 Lancet Gastroenterol Hepatol
2 Lancet HIV
4 Pediatr Infect Dis J
1 Pediatrics
1 PLoS Comput Biol
5 PLoS Med
13 PLoS One
1 Virology



    AIDS

  1. INZAULE SC, Hamers RL, Calis J, Boerma R, et al
    When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001696.
    >> Share

  2. AHMAD F, Mishra N, Ahrenstorf G, Franklin BS, et al
    Evidence of inflammasome activation and formation of monocyte-derived apoptosis-associated speck-like protein containing a caspase-recruitment domain specks in HIV-1 positive patients.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001693.
    >> Share

  3. MINGUEZ C, Garcia-Deltoro M, Flores J, Galindo MJ, et al
    Interferon-free therapy for treating HCV in difficult-to-treat HIV-coinfected patients as implemented in routine medical practice.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001699.
    >> Share

  4. PONGPIRUL W, Pongpirul K, Ananworanich J, Klinbuayaem V, et al
    Chronic kidney disease incidence and survival of Thai HIV-infected patients.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001698.
    >> Share

  5. SHARMA M, Smith JA, Farquhar C, Ying R, et al
    Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya: A mathematical modeling analysis.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001697.
    >> Share

  6. FAVARATO G, Townsend CL, Bailey H, Peters H, et al
    Protease inhibitors and preterm delivery: another piece in the puzzle.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001694.
    >> Share

  7. TRIPLETTE M, Justice A, Attia EF, Tate J, et al
    Markers of Chronic Obstructive Pulmonary Disease are associated with mortality in people living with HIV.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001701.
    >> Share

  8. CHOMONT N, Okoye AA, Favre D, Trautmann L, et al
    Wake me up before you go: A strategy to reduce the latent HIV reservoir.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001695.
    >> Share

  9. MATHABIRE RUCKER SC, Tayea A, Bitilinyu-Bangoh J, Bermudez-Aza EH, et al
    High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients: results from a cross-sectional survey in Malawi.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001700.
    >> Share

  10. MAKINSON A, Hayot M, Eymard-Duvernay S, Ribet C, et al
    HIV is associated with airway obstruction: a matched controlled study.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001691.
    >> Share

  11. LODI S, Gunthard HF, Dunn D, Garcia F, et al
    Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001692.
    >> Share

  12. SIEFRIED KJ, Mao L, Cysique LA, Rule J, et al
    Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive ART.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001685.
    >> Share


    AIDS Res Hum Retroviruses

  13. SANDERS-BEER BE, Voronin Y, McDonald D, Singh A, et al
    HARNESSING NOVEL IMAGING APPROACHES TO GUIDE HIV PREVENTION AND CURE DISCOVERIES - A NATIONAL INSTITUTES OF HEALTH AND GLOBAL HIV VACCINE ENTERPRISE 2017 MEETING REPORT.
    AIDS Res Hum Retroviruses. 2017 Nov 16. doi: 10.1089/AID.2017.0216.
    >> Share

  14. BOEHM D, Ott M
    Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond.
    AIDS Res Hum Retroviruses. 2017;33.
    >> Share

  15. CHRISTENSEN-QUICK A, Vanpouille C, Lisco A, Gianella S, et al
    Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire.
    AIDS Res Hum Retroviruses. 2017;33.
    >> Share

  16. TOUSSOVA O, Kozlov A, Verevochkin S, Lancaster K, et al
    A Cohort Approach to Real Time Detection of Acute HIV infections among People who Inject Drugs in St. Petersburg, Russia.
    AIDS Res Hum Retroviruses. 2017 Nov 16. doi: 10.1089/AID.2017.0076.
    >> Share

  17. VERMUND SH, Hamilton EL, Griffith S, Jennings L, et al
    Recruitment of underrepresented minority researchers into HIV prevention research: The HIV Prevention Trials Network (HPTN) Scholars Program.
    AIDS Res Hum Retroviruses. 2017 Nov 16. doi: 10.1089/AID.2017.0093.
    >> Share

  18. MENDEZ-LAGARES G, Lu D, Merriam D, Baker CA, et al
    IL-21 Therapy Controls Immune Activation and Maintains Antiviral CD8+ T Cell Responses in Acute Simian Immunodeficiency Virus Infection.
    AIDS Res Hum Retroviruses. 2017;33.
    >> Share


    Ann Intern Med

  19. PAULES CI, Eisinger RW, Marston HD, Fauci AS, et al
    What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats.
    Ann Intern Med. 2017 Nov 14. doi: 10.7326/M17-2496.
    >> Share


    Antimicrob Agents Chemother

  20. VAN DER LAAN LE, Garcia-Prats AJ, Schaaf HS, Tikiso T, et al
    Pharmacokinetics and drug-drug interactions of lopinavir/ritonavir administered with first and second-line antituberculosis drugs in HIV-infected children treated for multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.00420.
    >> Share

  21. DENTI P, Garcia-Prats AJ, Draper HR, Wiesner L, et al
    Levofloxacin population pharmacokinetics in South African children treated for multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01521.
    >> Share

  22. KAKADIYA PP, Higginson RT, Fulco PP
    Ritonavir-boosted protease inhibitors but not cobicistat appear safe in HIV-positive patients ingesting dabigatran.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.02275.
    >> Share


    Br J Haematol

  23. OKSENHENDLER E, Boutboul D, Fajgenbaum D, Mirouse A, et al
    The full spectrum of Castleman disease: 273 patients studied over 20 years.
    Br J Haematol. 2017 Nov 16. doi: 10.1111/bjh.15019.
    >> Share


    Clin Infect Dis

  24. MAHESWARAN H, Clarke A, MacPherson P, Kumwenda F, et al
    Cost-effectiveness of community-based HIV self-testing in Blantyre, Malawi.
    Clin Infect Dis. 2017 Nov 9. doi: 10.1093.
    >> Share

  25. WONG C, Gange SJ, Moore RD, Justice AC, et al
    Multimorbidity Among Persons Living with HIV in the U.S.
    Clin Infect Dis. 2017 Nov 15. doi: 10.1093.
    >> Share

  26. BEDIMO RJ, Adams-Huet B, Poindexter J, Brown G, et al
    The Differential Effects of HIV and HCV on Bone Micro-Architecture and Fracture risk.
    Clin Infect Dis. 2017 Nov 14. doi: 10.1093/cid/cix1011.
    >> Share

  27. VEIT O, Domingo C, Niedrig M, Staehelin C, et al
    Long-term immune response to yellow fever vaccination in HIV-infected individuals depends on HIV-RNA suppression status: Implications for vaccination schedule.
    Clin Infect Dis. 2017 Nov 11. doi: 10.1093.
    >> Share

  28. MCDONALD CR, Conroy AL, Gamble JL, Papp E, et al
    Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy.
    Clin Infect Dis. 2017 Nov 10. doi: 10.1093.
    >> Share


    J Acquir Immune Defic Syndr

  29. NAKIWALA JK, Walker NF, Diedrich CR, Worodria W, et al
    Neutrophil activation and enhanced release of granule products in HIV-TB immune reconstitution inflammatory syndrome.
    J Acquir Immune Defic Syndr. 2017 Nov 6. doi: 10.1097/QAI.0000000000001582.
    >> Share

  30. STEVENS ER, Nucifora K, Zhou Q, Braithwaite RS, et al
    Cost-Effectiveness Of Peer- Versus Venue-Based Approaches For Detecting Undiagnosed Hiv Among Heterosexuals In High-Risk New York City Neighborhoods.
    J Acquir Immune Defic Syndr. 2017 Nov 6. doi: 10.1097/QAI.0000000000001578.
    >> Share

  31. GUNARATNAM P, McManus H, Watchirs-Smith L, McGregor S, et al
    People Born In Non-Main English Speaking Countries Are Less Likely To Start Hiv Treatment Early In Australia: A National Cohort Analysis, 2014-15.
    J Acquir Immune Defic Syndr. 2017 Nov 6. doi: 10.1097/QAI.0000000000001585.
    >> Share

  32. LOGIE CH, Lacombe-Duncan A, Wang Y, Kaida A, et al
    Pathways from Hiv-Related Stigma to Antiretroviral Therapy Measures in The Hiv Care Cascade for Women Living with Hiv in Canada.
    J Acquir Immune Defic Syndr. 2017 Nov 8. doi: 10.1097/QAI.0000000000001589.
    >> Share

  33. MORGAN E, Skaathun B, Duvoisin R, Michaels S, et al
    Are Hiv Seroconversions Among Young Men Who Have Sex With Men Associated With Social Network Proximity To Recently Or Long-Term Hiv-Infected Individuals?
    J Acquir Immune Defic Syndr. 2017 Nov 8. doi: 10.1097/QAI.0000000000001586.
    >> Share

  34. ROBINSON JA, Marzinke MA, Fuchs EJ, Bakshi RP, et al
    Comparison Of The Pharmacokinetics And Pharmacodynamics Of Single-Dose Tenofovir Vaginal Film And Gel Formulation (Fame-05).
    J Acquir Immune Defic Syndr. 2017 Nov 7. doi: 10.1097/QAI.0000000000001587.
    >> Share

  35. MUGWANYA KK, Baeten JM, Wyatt C, Mugo NR, et al
    Frequency of monitoring kidney function in HIV-uninfected persons using daily oral tenofovir disoproxil fumarate pre-exposure prophylaxis.
    J Acquir Immune Defic Syndr. 2017 Nov 6. doi: 10.1097/QAI.0000000000001575.
    >> Share

  36. MMBAGA EJ, Moen K, Leyna GH, Mpembeni R, et al
    Hiv Prevalence and Associated Risk Factors Among Men Who Have Sex With Men in Dar Es Salaam, Tanzania.
    J Acquir Immune Defic Syndr. 2017 Nov 13. doi: 10.1097/QAI.0000000000001593.
    >> Share

  37. GOLUB SA, Lelutiu-Weinberger C, Surace A
    An Experimental Investigation of Implicit Hiv And Prep Stigma: Evidence For Ancillary Benefits of Prep Use.
    J Acquir Immune Defic Syndr. 2017 Nov 13. doi: 10.1097/QAI.0000000000001592.
    >> Share

  38. KAY ES, Rice WS, Crockett KB, Atkins GC, et al
    Experienced Hiv-Related Stigma in Healthcare and Community Settings: Mediated Associations With Psychosocial and Health Outcomes.
    J Acquir Immune Defic Syndr. 2017 Nov 13. doi: 10.1097/QAI.0000000000001590.
    >> Share

  39. FARHADIAN S, Jalbert E, Deng Y, Goetz MB, et al
    HIV and Age Do Not Synergistically Affect Age-Related T cell Markers.
    J Acquir Immune Defic Syndr. 2017 Nov 13. doi: 10.1097/QAI.0000000000001595.
    >> Share

  40. ERLANDSON KM, Lake JE, Sim M, Falutz J, et al
    Bone Mineral Density Declines Twice as Quickly Among HIV-Infected Women Compared to Men.
    J Acquir Immune Defic Syndr. 2017 Nov 11. doi: 10.1097/QAI.0000000000001591.
    >> Share


    J Am Acad Dermatol

  41. WARREN S, Kheterpal M, Myskowski PL, Moskowitz A, et al
    Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control study.
    J Am Acad Dermatol. 2017 Nov 10. pii: S0190-9622(17)32339.
    >> Share


    J Clin Oncol

  42. COLON-LOPEZ V, Shiels MS, Machin M, Ortiz AP, et al
    Anal Cancer Risk Among People With HIV Infection in the United States.
    J Clin Oncol. 2017 Nov 15:JCO2017749291. doi: 10.1200/JCO.2017.74.9291.
    >> Share


    J Infect Dis

  43. STEBA GS, Koekkoek SM, Vanhommerig JW, Brinkman K, et al
    DC-SIGN Polymorphisms Associated with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users.
    J Infect Dis. 2017 Nov 13. doi: 10.1093.
    >> Share

  44. HUANG YA, Tao G, Samandari T, Hoover KW, et al
    Laboratory Testing of a Cohort of Commercially Insured Users of HIV Preexposure Prophylaxis in the United States, 2011-2015.
    J Infect Dis. 2017 Nov 14. doi: 10.1093.
    >> Share

  45. YEN YF, Lan YC, Huang CT, Jen IA, et al
    Human Immunodeficiency Virus Infection Increases the Risk of Incident Autoimmune Hemolytic Anemia: A Population-Based Cohort Study in Taiwan.
    J Infect Dis. 2017;216:1000-1007.
    >> Share


    J Virol

  46. CHAILLON A, Gianella S, Lada SM, Perez-Santiago J, et al
    Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.
    J Virol. 2017 Nov 15. pii: JVI.01589-17. doi: 10.1128/JVI.01589.
    >> Share

  47. WHITE E, Wu F, Chertova E, Bess J, et al
    Truncating the Gp41 Cytoplasmic Tail of SIV Decreases Sensitivity to Neutralizing Antibodies without Increasing Envelope Content of Virions.
    J Virol. 2017 Nov 15. pii: JVI.01688-17. doi: 10.1128/JVI.01688.
    >> Share

  48. YOON CH, Kim SY, Byeon SE, Jeong Y, et al
    Correction for Yoon et al., "p53-Derived Host Restriction of HIV-1 Replication by Protein Kinase R-Mediated Tat Phosphorylation and Inactivation".
    J Virol. 2017;91.
    >> Share


    Lancet Gastroenterol Hepatol

  49. SONDERUP MW, Afihene M, Ally R, Apica B, et al
    Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030.
    Lancet Gastroenterol Hepatol. 2017;2:910-919.
    >> Share


    Lancet HIV

  50. PRENDERGAST AJ, Penazzato M
    Timing of antiretroviral therapy in children with advanced HIV.
    Lancet HIV. 2017 Nov 14. pii: S2352-3018(17)30193.
    >> Share

  51. NJUGUNA IN, Cranmer LM, Otieno VO, Mugo C, et al
    Urgent versus post-stabilisation antiretroviral treatment in hospitalised HIV-infected children in Kenya (PUSH): a randomised controlled trial.
    Lancet HIV. 2017 Nov 14. pii: S2352-3018(17)30167.
    >> Share


    Pediatr Infect Dis J

  52. CORRIGAN B, Mukui I, Mulenga L, Mthethwa N, et al
    Characteristics of Treatment-Experienced HIV-infected African Children and Adolescents Initiating Darunavir and/or Etravirine-based Antiretroviral Treatment.
    Pediatr Infect Dis J. 2017 Nov 14. doi: 10.1097/INF.0000000000001843.
    >> Share

  53. MANDALAKAS AM, Highsmith HY, Harris NM, Pawlicka A, et al
    T-SPOT.TB(R) Performance in Routine Pediatric Practice in a Low TB Burden Setting.
    Pediatr Infect Dis J. 2017 Nov 14. doi: 10.1097/INF.0000000000001792.
    >> Share

  54. SUCCI RC, Krauss MR, Harris DR, Machado DM, et al
    Immunity Following Childhood Vaccinations in Perinatally HIV-Exposed Children with and without HIV Infection in Latin America.
    Pediatr Infect Dis J. 2017 Nov 14. doi: 10.1097/INF.0000000000001831.
    >> Share

  55. DEHORITY W, Viani RM, Araneta MRG, Lopez G, et al
    Comparison of the QuantiFERON TB Gold In-tube Assay With Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection Among HIV-infected and Uninfected Children.
    Pediatr Infect Dis J. 2017;36:e317-e321.
    >> Share


    Pediatrics

  56. GREINER MV, Beal SJ, Nause K, Staat MA, et al
    Laboratory Screening for Children Entering Foster Care.
    Pediatrics. 2017 Nov 15. pii: e20163778. doi: 10.1542/peds.2016-3778.
    >> Share


    PLoS Comput Biol

  57. MCCLOSKEY RM, Poon AFY
    A model-based clustering method to detect infectious disease transmission outbreaks from sequence variation.
    PLoS Comput Biol. 2017;13:e1005868.
    >> Share


    PLoS Med

  58. ELUL B, Lamb MR, Lahuerta M, Abacassamo F, et al
    A combination intervention strategy to improve linkage to and retention in HIV care following diagnosis in Mozambique: A cluster-randomized study.
    PLoS Med. 2017;14:e1002433.
    >> Share

  59. KATZ IT, Kaplan R, Fitzmaurice G, Leone D, et al
    Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    PLoS Med. 2017;14:e1002434.
    >> Share

  60. MORRIS L, Mkhize NN
    Prospects for passive immunity to prevent HIV infection.
    PLoS Med. 2017;14:e1002436.
    >> Share

  61. SZUBERT AJ, Prendergast AJ, Spyer MJ, Musiime V, et al
    Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    PLoS Med. 2017;14:e1002432.
    >> Share

  62. MAYER KH, Seaton KE, Huang Y, Grunenberg N, et al
    Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
    PLoS Med. 2017;14:e1002435.
    >> Share


    PLoS One

  63. GARRIGA C, Manzanares-Laya S, Garcia de Olalla P, Gorrindo P, et al
    Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns.
    PLoS One. 2017;12:e0187893.
    >> Share

  64. LEDIKWE JH, Ramabu NM, Spees LP, Barnhart S, et al
    Early resumption of sexual activity following voluntary medical male circumcision in Botswana: A qualitative study.
    PLoS One. 2017;12:e0186831.
    >> Share

  65. LAY P, An S, Soeung S, Srey PS, et al
    Ten year experience with antiretroviral treatment in Cambodia: Trends in patient characteristics and treatment outcomes.
    PLoS One. 2017;12:e0185348.
    >> Share

  66. KHAC HAI N, Lawpoolsri S, Jittamala P, Thi Thu Huong P, et al
    Practices in security and confidentiality of HIV/AIDS patients' information: A national survey among staff at HIV outpatient clinics in Vietnam.
    PLoS One. 2017;12:e0188160.
    >> Share

  67. MILLER JC, Slim AC
    Saturation effects and the concurrency hypothesis: Insights from an analytic model.
    PLoS One. 2017;12:e0187938.
    >> Share

  68. MUSUMARI PM, Tangmunkongvorakul A, Srithanavibooncha K, Feldman MD, et al
    Socio-behavioral risk factors among older adults living with HIV in Thailand.
    PLoS One. 2017;12:e0188088.
    >> Share

  69. TIAN T, Mijiti P, Bingxue H, Fadong Z, et al
    Prevalence and risk factors of anal human papillomavirus infection among HIV-negative men who have sex with men in Urumqi city of Xinjiang Uyghur Autonomous Region, China.
    PLoS One. 2017;12:e0187928.
    >> Share

  70. LIU TH, Chung RH, Wang SC, Fang CP, et al
    Missense mutation at CLDN8 associated with a high plasma interferon gamma-inducible protein 10 level in methadone-maintained patients with urine test positive for morphine.
    PLoS One. 2017;12:e0187639.
    >> Share

  71. ONYANGO DO, Yuen CM, Cain KP, Ngari F, et al
    Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya.
    PLoS One. 2017;12:e0188235.
    >> Share

  72. SRITHANAVIBOONCHAI K, Chariyalertsak S, Nontarak J, Assanangkornchai S, et al
    Stigmatizing attitudes toward people living with HIV among general adult Thai population: Results from the 5th Thai National Health Examination Survey (NHES).
    PLoS One. 2017;12:e0187231.
    >> Share

  73. CHIPUNGU J, Bosomprah S, Zanolini A, Thimurthy H, et al
    Understanding linkage to care with HIV self-test approach in Lusaka, Zambia - A mixed method approach.
    PLoS One. 2017;12:e0187998.
    >> Share

  74. DECAMP AC, Rolland M, Edlefsen PT, Sanders-Buell E, et al
    Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.
    PLoS One. 2017;12:e0185959.
    >> Share

  75. KOWALSKA JD, Wojcik G, Rutkowski J, Ankiersztejn-Bartczak M, et al
    Modelling the cost-effectiveness of HIV care shows a clear benefit when transmission risk is considered in the calculations - A message for Central and Eastern Europe.
    PLoS One. 2017;12:e0186131.
    >> Share


    Virology

  76. LIU Y, Chen J, Nikolaitchik OA, Desimmie BA, et al
    The roles of five conserved lentiviral RNA structures in HIV-1 replication.
    Virology. 2017;514:1-8.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016